XML 19 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Provision for Income Taxes (Tables)
12 Months Ended
Apr. 30, 2015
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
The components of the provision (benefit) for income taxes are as follows (in thousands):
 
 
 
Year Ended April 30, 2015
 
 
 
Federal
 
State
 
Foreign
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
$
-
 
$
3
 
$
124
 
$
127
 
Deferred
 
 
(25,948)
 
 
(1,771)
 
 
8
 
 
(27,711)
 
Change in valuation allowance
 
 
25,948
 
 
1,771
 
 
(8)
 
 
27,711
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
$
-
 
$
3
 
$
124
 
$
127
 
  
 
 
Year Ended April 30, 2014
 
 
 
Federal
 
State
 
Foreign
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
$
-
 
$
5
 
$
12
 
$
17
 
Deferred
 
 
(2,015)
 
 
(148)
 
 
-
 
 
(2,163)
 
Change in valuation allowance
 
 
2,015
 
 
148
 
 
-
 
 
2,163
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
$
-
 
$
5
 
$
12
 
$
17
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
A reconciliation between the Company’s effective tax rate and the United States statutory tax rate for the years ended April 30, 2015 and 2014 is as follows:
 
 
Year Ended April 30,
 
 
2015
 
 
2014
 
 
 
 
 
 
 
 
 
 
Federal income tax at statutory rate
 
 
34.0
%
 
 
34.0
%
State income tax, net of federal benefit
 
 
2.6
 
 
 
2.1
 
Permanent differences
 
 
0.9
 
 
 
(5.6)
 
Increase in uncertain tax position
 
 
(0.8)
 
 
 
-
 
Other
 
 
(6.9)
 
 
 
(2.1)
 
Change in valuation allowance
 
 
(30.8)
 
 
 
(27.2)
 
Changes in tax rates
 
 
-
 
 
 
(1.4)
 
 
 
 
 
 
 
 
 
 
Income tax expense
 
 
(1.1)
%
 
 
(0.2)
%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Significant components of the Company’s deferred tax assets and liabilities as of April 30, 2015 and 2014 consist of the following (in thousands):
 
 
 
As of April 30,
 
 
 
2015
 
2014
 
 
 
 
 
 
 
 
 
Accrued liabilities
 
$
21
 
$
38
 
Depreciation and amortization
 
 
-
 
 
9
 
State taxes
 
 
1
 
 
1
 
Stock-based compensation expense
 
 
4,803
 
 
4,511
 
Capitalized research and development costs
 
 
433
 
 
556
 
Foreign net operating loss carry-forward
 
 
235
 
 
244
 
Net operating loss carry-forward
 
 
9,719
 
 
5,608
 
 
 
 
 
 
 
 
 
Total deferred tax assets
 
 
15,212
 
 
10,968
 
Less: Valuation allowance
 
 
(15,212)
 
 
(10,968)
 
 
 
 
 
 
 
 
 
Net deferred tax asset
 
$
-
 
$
-
 
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
The following table indicates the changes to the Company’s uncertain tax positions for the period and years ended April 30, 2015 and 2014 in thousands:
 
 
 
Year Ended April 30,
 
 
 
2015
 
2014
 
 
 
 
 
 
 
 
 
Balance, beginning of the year
 
$
-
 
$
-
 
Addition based on tax positions related to prior years
 
 
21
 
 
-
 
Addition based on tax positions related to current year
 
 
79
 
 
-
 
 
 
 
 
 
 
 
 
Balance, end of year
 
$
100
 
$
-